Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
5
×
life sciences
national blog main
san francisco blog main
clinical trials
deals
fda
national top stories
new york blog main
new york top stories
san francisco top stories
abbvie
alzheimer's disease
biotech ipos
boston
cancer
cancer drugs
cancer immunotherapy
eli lilly
europe blog main
european society for medical oncology
investing
medicare
mirati therapeutics
national
startups
89bio
acute myeloid leukemia
adrian krainer
alexion pharmaceuticals
allergan
alx oncology
alzheimer europe conference
astrazeneca
autoimmune diseases
azacitidine
bain capital
berkeley lights
What
biotech
5
×
research
5
×
medicines
new
companies
drug
ipo
therapeutics
week
abbvie
aims
alliance
alzheimer’s
annual
approach
arrival
assessed
attention
based
bio
black
called
cancer
clinic
communities
conference
days
debuts
developing
diamond
drugs
editas
editing
eluded
epigenetic
epigenetics
esmo
europe
exits
experimental
Language
unset
Current search:
biotech
×
research
×
" boston top stories "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
